MUC1 expression by immunohistochemistry is associated with adverse pathologic features in prostate cancer: A multi-institutional study
Okyaz Eminaga, Wei Wei, Sarah J. Hawley, Heidi Auman, Lisa F. Newcomb, Jeff Simko, Antonio Hurtado-Coll, Dean A. Troyer, Peter R. Carroll, Martin E. Gleave, Daniel W. Lin, Peter S. Nelson, Ian M. Thompson, Lawrence D. True, Jesse K. McKenney, Ziding Feng, Ladan Fazli, James D. Brooks
Dive into the research topics of 'MUC1 expression by immunohistochemistry is associated with adverse pathologic features in prostate cancer: A multi-institutional study'. Together they form a unique fingerprint.